Viking Therapeutics Receives $24,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=549f0ea6-601a-43cc-b4f5-34e8c35e4d48
Date
4/29/2015
Company Name
Viking Therapeutics
Mailing Address
11119 North Torrey Pines Road La Jolla, CA 92037 USA
Company Description
Viking Therapeutics (NASDAQ: VKTX) is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.
Website
http://www.vikingtherapeutics.com
Transaction Type
IPO
Transaction Amount
$24,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms